2FZ9
Human Aldose Reductase complexed with inhibitor zopolrestat after six days soaking.
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | ROTATING ANODE |
Source details | RIGAKU RU300 |
Temperature [K] | 100 |
Detector technology | IMAGE PLATE |
Collection date | 2005-09-08 |
Detector | RIGAKU RAXIS IV |
Wavelength(s) | 1.5418 |
Spacegroup name | P 1 21 1 |
Unit cell lengths | 49.450, 67.100, 47.300 |
Unit cell angles | 90.00, 92.43, 90.00 |
Refinement procedure
Resolution | 50.000 - 1.600 |
R-factor | 0.164 |
Rwork | 0.162 |
R-free | 0.22300 |
Structure solution method | AB INITIO |
Starting model (for MR) | 1el3 |
RMSD bond length | 0.009 |
RMSD bond angle | 0.026 |
Data reduction software | CrystalClear ((MSC/RIGAKU)) |
Data scaling software | SCALEPACK |
Phasing software | CNS |
Refinement software | SHELXL-97 |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 50.000 | 1.630 |
High resolution limit [Å] | 1.600 | 1.600 |
Number of reflections | 35630 | |
<I/σ(I)> | 16.5 | 2.4 |
Completeness [%] | 87.5 | 80.4 |
Redundancy | 2.8 | 2.1 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, HANGING DROP | 5 | 293 | 50 mM ammonium citrate, 25 % PEG 6000, VAPOR DIFFUSION, HANGING DROP, temperature 293K |